Skip to main content

Board of Directors

Lif’s Board of Directors manages the Association and consists of 10 board members.

Chair & Vice Chair

Anders ThelborgChair



Executive Lead, Market Access, Policy & Government Affairs – European Markets
Bristol Myers Squibb Denmark
Mads W. Ø. Larsen1st Vice Chair



General Manager
Novo Nordisk Denmark A/S

Thea Larsen2nd Vice Chair

Business Director Oncology, Scandinavia & Country Lead Denmark
Abbvie

Board of Directors

Carole HassounGeneral Manager



Roche Pharmaceuticals A/S
Mari-Ann RetzManaging Director





UCB Nordic
Peter DrøidalCountry Manager Denmark




Novartis
Christof BischoffCountry Director




AstraZeneca
Søren Klein KristensenSenior Vice President, Region North – Central Europe & Partner Markets

Lundbeck Pharma
Anja VerhaugNordic General Manager


Leo Pharma Nordic
Tore von WürdenCountry Director Denmark/Norway/Iceland



Management

Thomas Senderovitz
Thomas Senderovitz CEO +45 39 27 60 60 ts@lif.dk Thomas Senderovitz | LinkedIn Læs mere